Top Markets
#1 Black Phoenix Black Phoenix +166.52%
#2 Islamic Coin Islamic Coin +158.25%
#3 Glidr Glidr +84.34%
#4 Test Test +21.69%
#5 Cryptopia Cryptopia +21.17%
#6 Quantum Resistant Ledger Quantum Resistant Ledger +18.52%
#7 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +18.45%
#8 Wrapped Bitcoin (PulseChain) Wrapped Bitcoin (PulseChain) +12.47%
#9 MarsCoin MarsCoin +11.59%
#10 DOVU DOVU +8.82%
Coin of the day
Black Phoenix Black Phoenix
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
Xeno Transplants Corporation Xeno Transplants Corporation

Xeno Transplants Corporation

XENO
Clasificación en acciones #42146
Xeno Transplants Corporation functions as a biotechnology firm dedicated to... Xeno Transplants Corporation functions as a biotechnology firm dedicated to research and development. Leveraging a specific licensing agreement with Massachusetts General Hospital, the company aims to innovate, produce, commercialize, and implement products and methodologies for public application in the field of xenotransplantation. The primary objective of this xenotransplantation research is to alleviate the critical scarcity of human cells, tissues, and organs required for medical transplants. This is achieved by pioneering techniques that enable the transfer of biological components—such as cells, tissues, and organs—from non-human species, including pigs, into human recipients. Established in 2004, Xeno Transplants Corporation maintains its headquarters in Brookline, Massachusetts.
Precio por acción
$0.0001
Última sincronización: 2026-08-11
Capitalización bursátil
$4.04K
Cambio (1 día)
0.00%
Cambio (1 año)
0.00%
País
CA
Comercio Xeno Transplants Corporation (XENO)

Categoría

Healthcare
Ratio P/S de Xeno Transplants Corporation (XENO)
Ratio P/S al 2026 TTM: 0
Según los informes financieros más recientes y el precio de las acciones de Xeno Transplants Corporation, el ratio P/S actual (TTM) es 0. Al final de 2026, el ratio P/S era 0.
Historial del ratio P/S de Xeno Transplants Corporation desde 2026 hasta 2026
Ratio P/S al final de cada año
Año Ratio P/S Cambiar
Not enough data for the provided dates.
Ratio P/S de empresas similares o competidoras
Empresa Ratio P/S Diferencia del ratio P/S País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
9.88 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
10.30 -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
4.98 -
BE
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
- -
KR